Central-memory lymphocyte therapy for liver cancer

What to clarify

Central-memory lymphocytes are a named immune-cell population, but the price row does not establish a particular manufactured product. To interpret the proposal, the team must distinguish the biological cell description from the intended liver-cancer treatment and provide the actual preparation and study information.

Before your consultation

Histology and stage; prior systemic and liver-directed treatment; latest scans; blood counts and liver function.

Use existing documents for the initial inquiry. The hospital should specify whether additional tests are needed after reviewing them. Arrange secure transfer of records through the care team; do not place sensitive records in a public message.

Evidence and limitations

The supplied price tables identify a named intervention and hospital, but contain no study reference, detailed safety information or patient-specific recommendation. They cannot establish current authorization, benefit, eligibility or availability. Ask for the exact product or cell preparation, the applicable clinical or research pathway and the consent information.

If offered as research, request the registry identifier, study phase, eligibility criteria, sponsor and follow-up obligations. A trial registration is a record of a study; it is not a guarantee that the intervention works.

Questions to ask

Price and quotation

A reference amount is not a total course price. Ask the provider to itemize assessment, testing, cell or product preparation, administration, admission, medicines and follow-up where applicable. Confirm the number of sessions, currency, quote validity and refund or cancellation terms. Accommodation, travel and Uwell coordination are separate unless the written quotation says otherwise.

Sources and editorial scope

Prepared by Uwell’s content team from the cited documents; not a clinician-reviewed recommendation. Source review: 10 October 2026.

• National Cancer Institute: liver cancer
• National Cancer Institute: T-cell transfer therapy

The clinical links provide background information. They do not verify the exact hospital programme, current authorization or an individualized treatment recommendation. The original provider must supply those details.

Original catalogue entries

• Client catalogue by specialty · row 22
• Client catalogue by hospital · row 10

Source publication date: not supplied. The figures remain source references rather than a current hospital quotation.